Clinical Trials Logo

Diabetic Neuropathies clinical trials

View clinical trials related to Diabetic Neuropathies.

Filter by:

NCT ID: NCT04943614 Completed - Clinical trials for Diabetic Neuropathies

Biodex Balance System Training in Diabetic Neuropathy

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Type II-diabetic neuropathy is the most common and correlated problem with diabetes that deteriorates with the passage of time. Balance disorders are also resulting of movement strategy damage, biomechanical and mechanical disorientation. The balance disorder has been reported to be related to abnormal somatosensory feedback, which is utilized in the development of an interior depiction of body motion and position (inner model) in the central nervous system. The Biodex stability system offers a system that can deliver particular hip and ankle postural training strategy with external biofeedback as a monitor to enhance the reduced subclinical limitations of patients with diabetic neuropathy.

NCT ID: NCT04894461 Not yet recruiting - Clinical trials for Peripheral Neuropathy

Efficacy of Moxibustion in Diabetes Peripheral Neuropathy

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

This pragmatic randomized controlled study aimed to evaluate the effectiveness and safety of moxibustion therapy on diabetes peripheral neuropathy.

NCT ID: NCT04873232 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy

A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy

REGAiN-1B
Start date: May 17, 2021
Phase: Phase 3
Study type: Interventional

To evaluate the durability of efficacy and long-term safety of intramuscular (IM) administration of Engensis or Placebo that was administered in the double-blind, randomized, VMDN-003-2 Placebo-controlled Phase 3 Study.

NCT ID: NCT04857957 Completed - Clinical trials for Painful Diabetic Neuropathy

Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN

Start date: April 14, 2021
Phase: Phase 1
Study type: Interventional

A Phase 1b study to evaluate the safety, tolerability and pharmacokinetics of multiple ascending doses of CNTX-6016 in healthy subjects and a single cohort to evaluate painful diabetic neuropathy.

NCT ID: NCT04846673 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy

Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy

OPTIMUM
Start date: May 14, 2021
Phase: Phase 4
Study type: Interventional

This study is a randomized, parallel, open-label, multicenter, phase IV clinical trial to assess the efficacy and safety of pregabalin and alpha-lipoic acid combination compared with each monotherapy in patients with diabetic peripheral neuropathy for 12 weeks.

NCT ID: NCT04841720 Recruiting - Clinical trials for Diabetic Neuropathies

A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets

Start date: April 1, 2021
Phase: Phase 1
Study type: Interventional

This study is a single-center, open, single-arm study, conducted in healthy Chinese populations, and plans to enroll 22 healthy adult subjects (the ratio of either sex is not less than 1/3).

NCT ID: NCT04833660 Not yet recruiting - Clinical trials for Diabetic Peripheral Neuropathic Pain

rTMS on Diabetic Peripheral Neuropathic Pain

Start date: April 30, 2021
Phase: N/A
Study type: Interventional

Background: Approximately half of the patients with long-standing diabetes are known to have diabetic peripheral neuropathy (DPN). Pain from DPN deteriorates the quality of life and hinders daily life activities. Objectives: This study aimed to evaluate the effect of high-frequency (10 Hz) repetitive transcranial magnetic stimulation (rTMS) on the left primary motor cortex (M1) for neuropathic pain in the lower extremities due to DPN. Methods: In this randomized trial, 22 patients with DPN will randomly assign to the rTMS group (10 Hz stimulation, five sessions) or the sham group. A numeric rating scale (NRS) will use to measure pain intensity before treatment and after 1 day and 1 week of the treatment. Physical and mental health status will evaluate using the Short Form 36-Item Health Survey (SF-36), comprising two subscales (physical and mental component scores [PCSs and MCSs]), at 1-week post-treatment.

NCT ID: NCT04832464 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy (DPN)

BRACE(Balance, Resistance, Aerobic and Cognitive Exercise) Protocol for Diabetic).Peripheral Neuropathic Patients.

Start date: March 30, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the effects of the BRACE( Balance, Resistance, Aerobic and Cognitive Exercise) protocol for balance training in patients with Diabetic Peripheral Neuropathy. A Randomized Control Trial is being conducted at Railways General Hospital, Rawalpindi. The sample size was calculated through the open epi tool. A total of 60 patients are divided into two groups, 30 participants in the experimental group and 30 participants in the control group. The study duration will be six months. The sampling technique applied was simple random sampling for recruitment and group randomization using the sealed envelope method. Patients with the age of 40-65 years having type II diabetes for more than 5 years are included in the study. Tools used in the study are Berg balance scale, timed up and go test, functional reach test, Montreal Cognitive Assessment scale (MOCA), and force plate. Data will be analyzed through Statistical Package for the Social Sciences (SPSS), version 21.

NCT ID: NCT04813146 Recruiting - Clinical trials for Diabetic Neuropathies

Role of Synchronized Lifestyle Modification Program on Diabetic Neuropathy Taking Oral Hypoglycemics

Start date: February 5, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to determine the combined effect of SLP along with Physiotherapy in improving Type 2 DPN patients taking OHAs and GLP-1 analogues.

NCT ID: NCT04813133 Recruiting - Clinical trials for Diabetic Neuropathies

Role of Synchronized Lifestyle Modification Program in Insulin Dependent Diabetic Peripheral Neuropathy Patients

Start date: February 5, 2021
Phase: N/A
Study type: Interventional

This study aims to determine the role of Synchronized Lifestyle modification program along with Physiotherapy on the symptoms of DPN in patients on insulin therapy.